Skip to menu Skip to content Skip to footer

2006

Conference Publication

Modified influenza virosomes for gene delivery

Khoshnejad, M., Toth, I., Young, P. R. and Minchin, R. F. (2006). Modified influenza virosomes for gene delivery. Brisbane Biological & Organic Chemistry Symposium, Brisbane, Qld, 24 Nov 2006.

Modified influenza virosomes for gene delivery

2006

Conference Publication

Liposaccharides in peptide, gene and vaccine delivery

Toth, I., Moyle, P. M., Koda, Y., Olive, C. and Good, M. F. (2006). Liposaccharides in peptide, gene and vaccine delivery. 33rd Annual Meeting and Exposition of the Controlled Release Soy, Vienna, 22-26 July, 2006.

Liposaccharides in peptide, gene and vaccine delivery

2006

Journal Article

Particulate systems as adjuvants and carriers for peptide and protein antigens

Liang, M T, Davies, N M, Blanchfield, J T and Toth, I (2006). Particulate systems as adjuvants and carriers for peptide and protein antigens. Current Drug Delivery, 3 (4), 379-388. doi: 10.2174/156720106778559029

Particulate systems as adjuvants and carriers for peptide and protein antigens

2006

Conference Publication

Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro

Liang, Ming T., Hennessy, Tania, Toth, Istvan, Davies, Nigel M. and Hook, Sarah (2006). Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro. International Conference on Nanoscience and Nanotechnology, Brisbane, QLD, Australia, 3-7 July 2006. Piscataway, NJ, United States: IEEE. doi: 10.1109/ICONN.2006.340608

Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro

2006

Conference Publication

Liposaccharides in peptide, gene and vaccine delivery

Toth, I., Moyle, P. M., Simerska, P., Fujita, Y., Olive, C. and Good, M. F. (2006). Liposaccharides in peptide, gene and vaccine delivery. Drug Design Amongst the Vines, Hunter Valley, 3 - 7 December, 2006.

Liposaccharides in peptide, gene and vaccine delivery

2006

Conference Publication

Enhancement of drug oral absorption - effect of lipidic conjugation on the stability and permeability of a dipeptide amide derivative in Caco-2 models

Bergeon, J and Toth, I (2006). Enhancement of drug oral absorption - effect of lipidic conjugation on the stability and permeability of a dipeptide amide derivative in Caco-2 models. Brisbane Biological & Organic Chemistry Symposium, Brisbane, 24 November 2006.

Enhancement of drug oral absorption - effect of lipidic conjugation on the stability and permeability of a dipeptide amide derivative in Caco-2 models

2006

Journal Article

Towards the synthesis of a highly pure, multiepitopic, mucosal group A streptoccal lipopeptide vaccine

Moyle, P. M., Olive, C., Ho, M.-F., Burgess, M., Karpati, L., Good, M. F. and Toth, I. (2006). Towards the synthesis of a highly pure, multiepitopic, mucosal group A streptoccal lipopeptide vaccine. International Congress Series, 1289, 324-328. doi: 10.1016/j.ics.2005.11.084

Towards the synthesis of a highly pure, multiepitopic, mucosal group A streptoccal lipopeptide vaccine

2006

Journal Article

Epidermal penetration of a therapeutic peptide by lipid conjugation; Stereo-selective peptide availability of a topical diastereomeric lipopeptide

Caccetta, R., Blanchfield, J. T., Harrison, J., Toth, I. and Benson, H. A. E. (2006). Epidermal penetration of a therapeutic peptide by lipid conjugation; Stereo-selective peptide availability of a topical diastereomeric lipopeptide. International Journal of Peptide Research and Therapeutics, 12 (3), 327-333. doi: 10.1007/s10989-006-9024-5

Epidermal penetration of a therapeutic peptide by lipid conjugation; Stereo-selective peptide availability of a topical diastereomeric lipopeptide

2006

Conference Publication

Liposaccharides in peptide, gene and vaccine delivery

Toth, I, Moyle, P. M., Koda, Y., Olive, C. and Good, M F (2006). Liposaccharides in peptide, gene and vaccine delivery. 10th Naples Workshop on Bioactive Peptides, Naples, 11-14 June, 2006.

Liposaccharides in peptide, gene and vaccine delivery

2006

Journal Article

Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system

Wu, S., Christopher, C., Koda, Y., Blanchfield, J. T. and Toth, I. (2006). Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system. Medicinal Chemistry, 2 (2), 203-211. doi: 10.2174/157340606776056205

Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the Caco-2 cell monolayer system

2006

Conference Publication

The chemo-enzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug delivery

Johnstone, Ken D., Dieckelmann, Manuela, Jennings, Michael P., Blanchfield, Joanne T. and Toth, Istvan (2006). The chemo-enzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug delivery. 19th American Peptide Symposium, San Diego, CA, United States, 18-23 June 2005. New York, NY, United States: Springer. doi: 10.1007/978-0-387-26575-9_221

The chemo-enzymatic synthesis of oligosaccharide-linked peptides aimed at improved drug delivery

2006

Conference Publication

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

Wimmer, N, Robinson, JA, Gopisetty-Venkatta, N, Roberts-Thomson, SJ, Monteith, GR and Toth, I (2006). Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells. 19th American Peptide Symposium, San Diego, CA, United States, June 18-23 2005. New York, N.Y., United States: Springer. doi: 10.1007/978-0-387-26575-9_148

Novel glyco-lipid-arsenicals(III) with anti-proliferative effects on MCF-7 human breast cancer cells

2006

Conference Publication

Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer

Simerska, P, Moyle, P. M., Olive, C., Sun, H., Ho, M.-F., Pandy, M.G., Dyer, J. R., Burgess, M L and Toth, I (2006). Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer. Brisbane Biological & Organic Chemistry Symposium, Brisbane, 24 November 2006.

Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer

2006

Journal Article

Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin

Hayes, Patricia Y., Ross, Benjamin P., Thomas, Bradley G. and Toth, Istvan (2006). Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin. Bioorganic & Medicinal Chemistry, 14 (1), 143-152. doi: 10.1016/j.bmc.2005.08.004

Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin

2006

Conference Publication

Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer

Simerska, P., Moyle, P. M., Olive, C., Sun, H. K., Ho, M. F., Pandy, M. G., Dyer, J. R., Burgess, M. L. and Toth, I. (2006). Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer. GPEN 2006, Lawrence, USA, 25-27 October, 2006.

Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer

2006

Conference Publication

Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system

Moyle, Peter Michael, Olive, Colleen, Karpati, Levente, Barozzi, Nadia, Ho, Mei-Fong, Dyer, Joanne, Sun, Hsien Kuo, Good, Michael and Toth, Istvan (2006). Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system. 6th Australian Peptide Conference, Whitsunday Islands, Australia, 9-14 October, 2005. Netherlands: Springer. doi: 10.1007/s10989-006-9021-8

Synthesis and immunological evaluation of M protein targeted tetra-valent and tri-valent group A streptococcal vaccine candidates based on the lipid-core peptide system

2006

Conference Publication

Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro

Liang, Ming T., Hennessy, Tania, Toth, Istvan, Davies, Nigel M. and Hook, Sarah (2006). Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro. International Conference on Nanoscience and Nanotechnology, Brisbane Australia, Jul 03-07, 2006. NEW YORK: IEEE.

Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro

2006

Conference Publication

Uptake of a multi-component non-viral gene delivery system and gene expression in mammalian cells

Yang, S, Coles, D. J., Esposito, A., Mitchell, D J, Toth, I and Minchin, R F (2006). Uptake of a multi-component non-viral gene delivery system and gene expression in mammalian cells. Annual Conference of the Australasian Pharmaceutical Science n, Adelaide, 3-5 December, 2006.

Uptake of a multi-component non-viral gene delivery system and gene expression in mammalian cells

2006

Conference Publication

Synthesis and characterisation of Trp modified Leu-Enkephalin analogues

Del Borgo, M, Wang, R., Toth, I and Blanchfield, J T (2006). Synthesis and characterisation of Trp modified Leu-Enkephalin analogues. Brisbane Biological & Organic Chemistry Symposium, Brisbane, 24 Nov 2006.

Synthesis and characterisation of Trp modified Leu-Enkephalin analogues

2006

Journal Article

Method for the synthesis of highly pure vaccines using the lipid core peptide system

Moyle, P. M., Olive, C., Good, M. F. and Toth, I. (2006). Method for the synthesis of highly pure vaccines using the lipid core peptide system. Journal of Peptide Science, 12 (12), 800-807. doi: 10.1002/psc.815

Method for the synthesis of highly pure vaccines using the lipid core peptide system